Abe, Yasuyuki <br/><br/>
Pharmacological characterization of RS-1259, an orally active dual inhibitor of acetylcholinesterase and serotonin transporter, in rodents: possible treatment of Alzheimer's disease.  [electronic resource] 

 -  Journal of pharmacological sciences  Sep 2003 
 - 95-105 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1347-8613 
<br/><br/><label>Standard No.: </label>10.1254/jphs.93.95  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetylcholinesterase--metabolism<br/>Administration, Oral<br/>Aging--drug effects<br/>Alzheimer Disease--drug therapy<br/>Animals<br/>Carbamates--chemistry<br/>Carrier Proteins--antagonists & inhibitors<br/>Cholinesterase Inhibitors--chemistry<br/>Fumarates--chemistry<br/>Hippocampus--drug effects<br/>Male<br/>Maze Learning--drug effects<br/>Membrane Glycoproteins--antagonists & inhibitors<br/>Membrane Transport Proteins<br/>Memory--drug effects<br/>Mice<br/>Microdialysis<br/>Motor Activity--drug effects<br/>Nerve Tissue Proteins--antagonists & inhibitors<br/>Rats<br/>Rats, Inbred F344<br/>Rats, Sprague-Dawley<br/>Rats, Wistar<br/>Serotonin Plasma Membrane Transport Proteins